Professor John Jacobi appeared in The Wall Street Journal regarding the last minute veto by Governor Chris Christie of a bill which would have created a health insurance exchange in New Jersey. The Journal reports: New Jersey Gov. Chris Christie on Thursday vetoed a bill to create a medical-insurance exchange, rejecting a key element of President […]
As much as I write about medical malpractice, it seems only fair that I devote a post and direct our fair readers to the other side of the bar: The Drug and Device blog put out by a number of Dechert, LLP attorneys involved in pharmaceutical and medical device product liability litigation– from the defense […]
Earlier this month, the First Circuit surprised observers when it held, in Bartlett v. Mutual Pharmaceutical, that a state law product liability suit founded on the claim that a generic drug was unreasonably dangerous due to a design defect was not preempted by the Federal Food, Drug, and Cosmetic Act (FDCA). In coming to its […]